UGT2B7 and cholestasis: In particular for diclofenac-induced cholestasis, it was suggested that allelic variants in UGT2B7, CYP2C8, and MRP2 may cause an increase in the level of reactive metabolites leading to protein-diclofenac adducts that then produce toxicity.